{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T18:20:52Z","timestamp":1780510852219,"version":"3.54.1"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,22]],"date-time":"2020-01-22T00:00:00Z","timestamp":1579651200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,22]],"date-time":"2020-01-22T00:00:00Z","timestamp":1579651200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100011512","name":"National Research Foundation","doi-asserted-by":"publisher","award":["2017M3A9B4042583"],"award-info":[{"award-number":["2017M3A9B4042583"]}],"id":[{"id":"10.13039\/100011512","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011512","name":"National Research Foundation","doi-asserted-by":"publisher","award":["2010-0024334"],"award-info":[{"award-number":["2010-0024334"]}],"id":[{"id":"10.13039\/100011512","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Tissue Eng Regen Med"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s13770-019-00233-8","type":"journal-article","created":{"date-parts":[[2020,1,22]],"date-time":"2020-01-22T10:03:51Z","timestamp":1579687431000},"page":"67-80","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Combination of Human Mesenchymal Stem Cells and Repetitive Transcranial Magnetic Stimulation Enhances Neurological Recovery of 6-Hydroxydopamine Model of Parkinsonian\u2019s Disease"],"prefix":"10.1007","volume":"17","author":[{"given":"Ji Yong","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Soo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Hoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Soo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byung Pil","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,22]]},"reference":[{"key":"233_CR1","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.nurt.2008.02.002","volume":"5","author":"AD Wu","year":"2008","unstructured":"Wu AD, Fregni F, Simon DK, Deblieck C, Pascual-Leone A. Noninvasive brain stimulation for Parkinson\u2019s disease and dystonia. Neurotherapeutics. 2008;5:345\u201361.","journal-title":"Neurotherapeutics"},{"key":"233_CR2","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/NRL.0000000000000188","volume":"23","author":"D Mendes Filho","year":"2018","unstructured":"Mendes Filho D, Ribeiro PDC, Oliveira LF, de Paula DRM, Capuano V, de Assun\u00e7\u00e3o TSF, et al. Therapy with mesenchymal stem cells in Parkinson disease: history and perspectives. Neurologist. 2018;23:141\u20137.","journal-title":"Neurologist"},{"key":"233_CR3","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.bbadis.2008.10.007","volume":"1792","author":"R Wijeyekoon","year":"2009","unstructured":"Wijeyekoon R, Barker RA. Cell replacement therapy for Parkinson\u2019s disease. Biochim Biophys Acta. 2009;1792:688\u2013702.","journal-title":"Biochim Biophys Acta"},{"key":"233_CR4","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/00001756-199902250-00027","volume":"10","author":"HR Siebner","year":"1999","unstructured":"Siebner HR, Mentschel C, Auer C, Conrad B. Repetitive transcranial magnetic stimulation has a beneficial effect on bradykinesia in Parkinson\u2019s disease. Neuroreport. 1999;10:589\u201394.","journal-title":"Neuroreport"},{"key":"233_CR5","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.bbrc.2006.02.191","volume":"343","author":"BC Kramer","year":"2006","unstructured":"Kramer BC, Woodbury D, Black IB. Adult rat bone marrow stromal cells express genes associated with dopamine neurons. Biochem Biophys Res Commun. 2006;343:1045\u201352.","journal-title":"Biochem Biophys Res Commun"},{"key":"233_CR6","doi-asserted-by":"crossref","first-page":"993","DOI":"10.3727\/000000007783472435","volume":"16","author":"J Wu","year":"2008","unstructured":"Wu J, Sun Z, Sun HS, Wu J, Weisel RD, Keating A, et al. Intravenously administered bone marrow cells migrate to damaged brain tissue and improve neural function in ischemic rats. Cell Transplant. 2008;16:993\u20131005.","journal-title":"Cell Transplant"},{"key":"233_CR7","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.coph.2006.02.008","volume":"6","author":"M Krampera","year":"2006","unstructured":"Krampera M, Pasini A, Pizzolo G, Cosmi L, Romagnani S, Annunziato F. Regenerative and immunomodulatory potential of mesenchymal stem cells. Curr Opin Pharmacol. 2006;6:435\u201341.","journal-title":"Curr Opin Pharmacol"},{"key":"233_CR8","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.neulet.2005.10.097","volume":"395","author":"MA Hellmann","year":"2006","unstructured":"Hellmann MA, Panet H, Barhum Y, Melamed E, Offen D. Increased survival and migration of engrafted mesenchymal bone marrow stem cells in 6-hydroxydopamine-lesioned rodents. Neurosci Lett. 2006;395:124\u20138.","journal-title":"Neurosci Lett"},{"key":"233_CR9","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3727\/096368908784423328","volume":"17","author":"AJ Monahan","year":"2008","unstructured":"Monahan AJ, Warren M, Carvey PM. Neuroinflammation and peripheral immune infiltration in Parkinson\u2019s disease: an autoimmune hypothesis. Cell Transplant. 2008;17:363\u201372.","journal-title":"Cell Transplant"},{"key":"233_CR10","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s13770-016-9093-2","volume":"13","author":"MT Liau","year":"2016","unstructured":"Liau MT, Amini F, Ramasamy TS. The therapeutic potential of stem cells and progenitor cells for the treatment of Parkinson\u2019s disease. Tissue Eng Regen Med. 2016;13:455\u201364.","journal-title":"Tissue Eng Regen Med"},{"key":"233_CR11","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/S0006-3223(01)01369-5","volume":"51","author":"P Zwanzger","year":"2002","unstructured":"Zwanzger P, Ella R, Keck ME, Rupprecht R, Padberg F. Occurrence of delusions during repetitive transcranial magnetic stimulation (rTMS) in major depression. Biol Psychiatry. 2002;51:602\u20133.","journal-title":"Biol Psychiatry"},{"key":"233_CR12","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1586\/erd.10.57","volume":"8","author":"PB Fitzgerald","year":"2011","unstructured":"Fitzgerald PB, Daskalakis ZJ. The effects of repetitive transcranial magnetic stimulation in the treatment of depression. Expert Rev Med Devices. 2011;8:85\u201395.","journal-title":"Expert Rev Med Devices"},{"key":"233_CR13","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00702-010-0578-1","volume":"118","author":"J Bentwich","year":"2011","unstructured":"Bentwich J, Dobronevsky E, Aichenbaum S, Shorer R, Peretz R, Khaigrekht M et al. Beneficial effect of repetitive transcranial magnetic stimulation combined with cognitive training for the treatment of Alzheimer\u2019s disease: a proof of concept study. J Neural Transm (Vienna). 2011;118:463\u201371.","journal-title":"J Neural Transm (Vienna)"},{"key":"233_CR14","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.expneurol.2011.04.010","volume":"230","author":"S Theilig","year":"2011","unstructured":"Theilig S, Podubecka J, B\u00f6sl K, Wiederer R, Nowak DA. Functional neuromuscular stimulation to improve severe hand dysfunction after stroke: does inhibitory rTMS enhance therapeutic efficiency? Exp Neurol. 2011;230:149\u201355.","journal-title":"Exp Neurol"},{"key":"233_CR15","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/PHM.0b013e318228bf0c","volume":"91","author":"M Corti","year":"2012","unstructured":"Corti M, Patten C, Triggs W. Repetitive transcranial magnetic stimulation of motor cortex after stroke: a focused review. Am J Phys Med Rehabil. 2012;91:254\u201370.","journal-title":"Am J Phys Med Rehabil"},{"key":"233_CR16","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1755-7682-1-2","volume":"1","author":"O Arias-Carri\u00f3n","year":"2008","unstructured":"Arias-Carri\u00f3n O. Basic mechanisms of rTMS: implications in Parkinson\u2019s disease. Int Arch Med. 2008;1:2.","journal-title":"Int Arch Med"},{"key":"233_CR17","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1177\/1545968312451915","volume":"27","author":"YR Yang","year":"2013","unstructured":"Yang YR, Tseng CY, Chiou SY, Liao KK, Cheng SJ, Lai KL, et al. Combination of rTMS and treadmill training modulates corticomotor inhibition and improves walking in Parkinson disease: a randomized trial. Neurorehabil Neural Repair. 2013;27:79\u201386.","journal-title":"Neurorehabil Neural Repair"},{"key":"233_CR18","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.brainres.2013.08.051","volume":"1537","author":"JY Lee","year":"2013","unstructured":"Lee JY, Kim SH, Ko AR, Lee JS, Yu JH, Seo JH, et al. Therapeutic effects of repetitive transcranial magnetic stimulation in an animal model of Parkinson\u2019s disease. Brain Res. 2013;1537:290\u2013302.","journal-title":"Brain Res"},{"key":"233_CR19","doi-asserted-by":"crossref","first-page":"RC157","DOI":"10.1523\/JNEUROSCI.21-15-j0003.2001","volume":"21","author":"AP Strafella","year":"2001","unstructured":"Strafella AP, Paus T, Barrett J, Dagher A. Repetitive transcranial magnetic stimulation of the human prefrontal cortex induces dopamine release in the caudate nucleus. J Neurosci. 2001;21:RC157.","journal-title":"J Neurosci."},{"key":"233_CR20","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1093\/brain\/awg268","volume":"126","author":"AP Strafella","year":"2003","unstructured":"Strafella AP, Paus T, Fraraccio M, Dagher A. Striatal dopamine release induced by repetitive transcranial magnetic stimulation of the human motor cortex. Brain. 2003;126:2609\u201315.","journal-title":"Brain"},{"key":"233_CR21","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1002\/mds.21460","volume":"22","author":"EM Khedr","year":"2007","unstructured":"Khedr EM, Rothwell JC, Shawky OA, Ahmed MA, Foly N, Hamdy A. Dopamine levels after repetitive transcranial magnetic stimulation of motor cortex in patients with Parkinson\u2019s disease: preliminary results. Mov Disord. 2007;22:1046\u201360.","journal-title":"Mov Disord"},{"key":"233_CR22","doi-asserted-by":"crossref","first-page":"e6725","DOI":"10.1371\/journal.pone.0006725","volume":"4","author":"SS Cho","year":"2009","unstructured":"Cho SS, Strafella AP. rTMS of the left dorsolateral prefrontal cortex modulates dopamine release in the ipsilateral anterior cingulate cortex and orbitofrontal cortex. PLoS One. 2009;4:e6725.","journal-title":"PLoS One"},{"key":"233_CR23","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.neulet.2015.07.038","volume":"604","author":"JY Lee","year":"2015","unstructured":"Lee JY, Park HJ, Kim JH, Cho BP, Cho SR, Kim SH. Effects of low- and high-frequency repetitive magnetic stimulation on neuronal cell proliferation and growth factor expression: a preliminary report. Neurosci Lett. 2015;604:167\u201372.","journal-title":"Neurosci Lett"},{"key":"233_CR24","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3389\/fneur.2018.00050","volume":"9","author":"A Baek","year":"2018","unstructured":"Baek A, Kim JH, Pyo S, Jung JH, Park EJ, Kim SH, et al. The differential effects of repetitive magnetic stimulation in an in vitro neuronal model of ischemia\/reperfusion injury. Front Neurol. 2018;9:50.","journal-title":"Front Neurol"},{"key":"233_CR25","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0893-133X(00)00099-3","volume":"23","author":"MB M\u00fcller","year":"2000","unstructured":"M\u00fcller MB, Toschi N, Kresse AE, Post A, Keck ME. Long-term repetitive transcranial magnetic stimulation increases the expression of brain-derived neurotrophic factor and cholecystokinin mRNA, but not neuropeptide tyrosine mRNA in specific areas of rat brain. Neuropsychopharmacology. 2000;23:205\u201315.","journal-title":"Neuropsychopharmacology"},{"key":"233_CR26","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1097\/00001756-200403220-00029","volume":"15","author":"F Angelucci","year":"2004","unstructured":"Angelucci F, Oliviero A, Pilato F, Saturno E, Dileone M, Versace V, et al. Transcranial magnetic stimulation and BDNF plasma levels in amyotrophic lateral sclerosis. Neuroreport. 2004;15:717\u201320.","journal-title":"Neuroreport"},{"key":"233_CR27","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3389\/fpsyt.2012.00012","volume":"3","author":"L Gedge","year":"2012","unstructured":"Gedge L, Beaudoin A, Lazowski L, du Toit R, Jokic R, Milev R. Effects of electroconvulsive therapy and repetitive transcranial magnetic stimulation on serum brain-derived neurotrophic factor levels in patients with depression. Front Psychiatry. 2012;3:12.","journal-title":"Front Psychiatry"},{"key":"233_CR28","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1097\/00001756-200105080-00050","volume":"12","author":"W Doi","year":"2001","unstructured":"Doi W, Sato D, Fukuzako H, Takigawa M. c-Fos expression in rat brain after repetitive transcranial magnetic stimulation. Neuroreport. 2001;12:1307\u201310.","journal-title":"Neuroreport"},{"key":"233_CR29","doi-asserted-by":"crossref","first-page":"11044","DOI":"10.1523\/JNEUROSCI.2125-11.2011","volume":"31","author":"HY Wang","year":"2011","unstructured":"Wang HY, Crupi D, Liu J, Stucky A, Cruciata G, Di Rocco A, et al. Repetitive transcranial magnetic stimulation enhances BDNF-TrkB signaling in both brain and lymphocyte. J Neurosci. 2011;31:11044\u201354.","journal-title":"J Neurosci"},{"key":"233_CR30","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.nurt.2008.02.003","volume":"5","author":"AL Peterson","year":"2008","unstructured":"Peterson AL, Nutt JG. Treatment of Parkinson\u2019s disease with trophic factors. Neurotherapeutics. 2008;5:270\u201380.","journal-title":"Neurotherapeutics"},{"key":"233_CR31","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S0006-8993(03)03053-1","volume":"983","author":"JY Chang","year":"2003","unstructured":"Chang JY, Shi LH, Luo F, Woodward DJ. High frequency stimulation of the subthalamic nucleus improves treadmill locomotion in unilateral 6-hydroxydopamine lesioned rats. Brain Res. 2003;983:174\u201384.","journal-title":"Brain Res"},{"key":"233_CR32","doi-asserted-by":"crossref","first-page":"13","DOI":"10.11637\/kjpa.2013.26.1.13","volume":"26","author":"JS Lee","year":"2013","unstructured":"Lee JS, Lee JY, Cho WG, Yang YC, Cho BP. Relationship between microglial activation and dopaminergic neuronal loss in 6-OHDA-induced Parkinsonian animal model. Korean J Phys Anthropol. 2013;26:13\u201323.","journal-title":"Korean J Phys Anthropol"},{"key":"233_CR33","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0014-2999(80)90515-4","volume":"67","author":"JL Hylden","year":"1980","unstructured":"Hylden JL, Wilcox GL. Intrathecal morphine in mice: a new technique. Eur J Pharmacol. 1980;67:313\u20136.","journal-title":"Eur J Pharmacol"},{"key":"233_CR34","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1007\/s00702-007-0748-y","volume":"114","author":"HJ Habisch","year":"2007","unstructured":"Habisch HJ, Janowski M, Binder D, Kuzma-Kozakiewicz M, Widmann A, Habich A, et al. Intrathecal application of neuroectodermally converted stem cells into a mouse model of ALS: limited intraparenchymal migration and survival narrows therapeutic effects. J Neural Transm (Vienna). 2007;114:1395\u2013406.","journal-title":"J Neural Transm (Vienna)"},{"key":"233_CR35","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.expneurol.2008.07.011","volume":"213","author":"E Morita","year":"2008","unstructured":"Morita E, Watanabe Y, Ishimoto M, Nakano T, Kitayama M, Yasui K, et al. A novel cell transplantation protocol and its application to an ALS mouse model. Exp Neurol. 2008;213:431\u20138.","journal-title":"Exp Neurol"},{"key":"233_CR36","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.neulet.2009.10.074","volume":"468","author":"H Kim","year":"2010","unstructured":"Kim H, Kim HY, Choi MR, Hwang S, Nam KH, Kim HC, et al. Dose-dependent efficacy of ALS-human mesenchymal stem cells transplantation into cisterna magna in SOD1-G93A ALS mice. Neurosci Lett. 2010;468:190\u20134.","journal-title":"Neurosci Lett"},{"key":"233_CR37","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/TA.0b013e31815b847d","volume":"64","author":"F Saito","year":"2008","unstructured":"Saito F, Nakatani T, Iwase M, Maeda Y, Hirakawa A, Murao Y, et al. Spinal cord injury treatment with intrathecal autologous bone marrow stromal cell transplantation: the first clinical trial case report. J Trauma. 2008;64:53\u20139.","journal-title":"J Trauma"},{"key":"233_CR38","doi-asserted-by":"crossref","first-page":"8750","DOI":"10.1073\/pnas.84.23.8750","volume":"84","author":"SM Pellis","year":"1987","unstructured":"Pellis SM, Pellis VC, Chesire RM, Rowland N, Teitelbaum P. Abnormal gait sequence in locomotion after atropine treatment of catecholamine-deficient akinetic rats. Proc Natl Acad Sci U S A. 1987;84:8750\u20133.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"233_CR39","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0166-4328(99)00068-6","volume":"104","author":"RE Johnson","year":"1999","unstructured":"Johnson RE, Schallert T, Becker JB. Akinesia and postural abnormality after unilateral dopamine depletion. Behav Brain Res. 1999;104:189\u201396.","journal-title":"Behav Brain Res"},{"key":"233_CR40","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1007\/s11517-012-0933-5","volume":"50","author":"HY Lee","year":"2012","unstructured":"Lee HY, Hsieh TH, Liang JI, Yeh ML, Chen JJ. Quantitative video-based gait pattern analysis for hemiparkinsonian rats. Med Biol Eng Comput. 2012;50:937\u201346.","journal-title":"Med Biol Eng Comput."},{"key":"233_CR41","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0006-8993(02)03222-5","volume":"952","author":"L Lorigados Pedre","year":"2002","unstructured":"Lorigados Pedre L, Pav\u00f3n Fuentes N, Alvarez Gonz\u00e1lez L, McRae A, Serrano S\u00e1nchez T, Blanco Lescano L, et al. Nerve growth factor levels in Parkinson disease and experimental parkinsonian rats. Brain Res. 2002;952:122\u20137.","journal-title":"Brain Res"},{"key":"233_CR42","first-page":"2677","volume":"9","author":"E Herr\u00e1n","year":"2014","unstructured":"Herr\u00e1n E, Requejo C, Ruiz-Ortega JA, Aristieta A, Igartua M, Bengoetxea H, et al. Increased antiparkinson efficacy of the combined administration of VEGF- and GDNF-loaded nanospheres in a partial lesion model of Parkinson\u2019s disease. Int J Nanomedicine. 2014;9:2677\u201387.","journal-title":"Int J Nanomedicine"},{"key":"233_CR43","doi-asserted-by":"crossref","first-page":"6251","DOI":"10.1523\/JNEUROSCI.4601-04.2005","volume":"25","author":"ZC Baquet","year":"2005","unstructured":"Baquet ZC, Bickford PC, Jones KR. Brain-derived neurotrophic factor is required for the establishment of the proper number of dopaminergic neurons in the substantia nigra pars compacta. J Neurosci. 2005;25:6251\u20139.","journal-title":"J Neurosci"},{"key":"233_CR44","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0304-3940(99)00463-2","volume":"270","author":"M Mogi","year":"1999","unstructured":"Mogi M, Togari A, Kondo T, Mizuno Y, Komure O, Kuno S, et al. Brain-derived growth factor and nerve growth factor concentrations are decreased in the substantia nigra in Parkinson\u2019s disease. Neurosci Lett. 1999;270:45\u20138.","journal-title":"Neurosci Lett"},{"key":"233_CR45","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1006\/exnr.2000.7483","volume":"166","author":"DW Howells","year":"2000","unstructured":"Howells DW, Porritt MJ, Wong JY, Batchelor PE, Kalnins R, Hughes AJ, et al. Reduced BDNF mRNA expression in the Parkinson\u2019s disease substantia nigra. Exp Neurol. 2000;166:127\u201335.","journal-title":"Exp Neurol"},{"key":"233_CR46","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1749-6632.1992.tb24578.x","volume":"648","author":"MB Spina","year":"1992","unstructured":"Spina MB, Hyman C, Squinto S, Lindsay RM. Brain-derived neurotrophic factor protects dopaminergic cells from 6-hydroxydopamine toxicity. Ann N Y Acad Sci. 1992;648:348\u201350.","journal-title":"Ann N Y Acad Sci"},{"key":"233_CR47","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1097\/00001756-199505300-00009","volume":"6","author":"CW Shults","year":"1995","unstructured":"Shults CW, Kimber T, Altar CA. BDNF attenuates the effects of intrastriatal injection of 6-hydroxydopamine. Neuroreport. 1995;6:1109\u201312.","journal-title":"Neuroreport"},{"key":"233_CR48","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0304-3940(94)90218-6","volume":"182","author":"BJ Hoffer","year":"1994","unstructured":"Hoffer BJ, Hoffman A, Bowenkamp K, Huettl P, Hudson J, Martin D, et al. Glial cell line-derived neurotrophic factor reverses toxin-induced injury to midbrain dopaminergic neurons in vivo. Neurosci Lett. 1994;182:107\u201311.","journal-title":"Neurosci Lett"},{"key":"233_CR49","doi-asserted-by":"crossref","first-page":"8274","DOI":"10.1073\/pnas.92.18.8274","volume":"92","author":"A Tomac","year":"1995","unstructured":"Tomac A, Widenfalk J, Lin LF, Kohno T, Ebendal T, Hoffer BJ, et al. Retrograde axonal transport of glial cell line-derived neurotrophic factor in the adult nigrostriatal system suggests a trophic role in the adult. Proc Natl Acad Sci U S A. 1995;92:8274\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"233_CR50","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1046\/j.1471-4159.2003.01657.x","volume":"85","author":"AD Cohen","year":"2003","unstructured":"Cohen AD, Tillerson JL, Smith AD, Schallert T, Zigmond MJ. Neuroprotective effects of prior limb use in 6-hydroxydopamine-treated rats: possible role of GDNF. J Neurochem. 2003;85:299\u2013305.","journal-title":"J Neurochem"},{"key":"233_CR51","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nm850","volume":"9","author":"SS Gill","year":"2003","unstructured":"Gill SS, Patel NK, Hotton GR, O\u2019Sullivan K, McCarter R, Bunnage M, et al. Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease. Nat Med. 2003;9:589\u201395.","journal-title":"Nat Med"},{"key":"233_CR52","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3171\/jns.2005.102.2.0216","volume":"102","author":"JT Slevin","year":"2005","unstructured":"Slevin JT, Gerhardt GA, Smith CD, Gash DM, Kryscio R, Young B. Improvement of bilateral motor functions in patients with Parkinson disease through the unilateral intraputaminal infusion of glial cell line-derived neurotrophic factor. J Neurosurg. 2005;102:216\u201322.","journal-title":"J Neurosurg"},{"key":"233_CR53","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/ana.20737","volume":"59","author":"AE Lang","year":"2006","unstructured":"Lang AE, Gill S, Patel NK, Lozano A, Nutt JG, Penn R, et al. Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease. Ann Neurol. 2006;59:459\u201366.","journal-title":"Ann Neurol"},{"key":"233_CR54","doi-asserted-by":"crossref","first-page":"999","DOI":"10.2174\/1381612053381620","volume":"11","author":"T Nagatsu","year":"2005","unstructured":"Nagatsu T, Sawada M. Inflammatory process in Parkinson\u2019s disease: role for cytokines. Curr Pharm Des. 2005;11:999\u20131016.","journal-title":"Curr Pharm Des"},{"key":"233_CR55","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.neulet.2005.12.042","volume":"398","author":"RK Chaturvedi","year":"2006","unstructured":"Chaturvedi RK, Shukla S, Seth K, Agrawal AK. Nerve growth factor increases survival of dopaminergic graft, rescue nigral dopaminergic neurons and restores functional deficits in rat model of Parkinson\u2019s disease. Neurosci Lett. 2006;398:44\u20139.","journal-title":"Neurosci Lett"},{"key":"233_CR56","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1152\/physrev.1999.79.4.1283","volume":"79","author":"CH Heldin","year":"1999","unstructured":"Heldin CH, Westermark B. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev. 1999;79:1283\u2013316.","journal-title":"Physiol Rev"},{"key":"233_CR57","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1007\/BF00229041","volume":"92","author":"G Nikkhah","year":"1993","unstructured":"Nikkhah G, Odin P, Smits A, Tingstr\u00f6m A, Othberg A, Brundin P, et al. Platelet-derived growth factor promotes survival of rat and human mesencephalic dopaminergic neurons in culture. Exp Brain Res. 1993;92:516\u201323.","journal-title":"Exp Brain Res"},{"key":"233_CR58","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/BF00242187","volume":"105","author":"A Othberg","year":"1995","unstructured":"Othberg A, Odin P, Ballagi A, Ahgren A, Funa K, Lindvall O. Specific effects of platelet derived growth factor (PDGF) on fetal rat and human dopaminergic neurons in vitro. Exp Brain Res. 1995;105:111\u201322.","journal-title":"Exp Brain Res"},{"key":"233_CR59","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0304-3940(96)12326-0","volume":"204","author":"K Pietz","year":"1996","unstructured":"Pietz K, Odin P, Funa K, Lindvall O. Protective effect of platelet-derived growth factor against 6-hydroxydopamine-induced lesion of rat dopaminergic neurons in culture. Neurosci Lett. 1996;204:101\u20134.","journal-title":"Neurosci Lett"},{"key":"233_CR60","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/0306-4522(96)00152-2","volume":"74","author":"K Funa","year":"1996","unstructured":"Funa K, Yamada N, Brodin G, Pietz K, Ahgren A, Wictorin K, et al. Enhanced synthesis of platelet-derived growth factor following injury induced by 6-hydroxydopamine in rat brain. Neuroscience. 1996;74:825\u201333.","journal-title":"Neuroscience"},{"key":"233_CR61","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1227\/01.NEU.0000141042.14476.3C","volume":"55","author":"A Mahmood","year":"2004","unstructured":"Mahmood A, Lu D, Chopp M. Marrow stromal cell transplantation after traumatic brain injury promotes cellular proliferation within the brain. Neurosurgery. 2004;55:1185\u201393.","journal-title":"Neurosurgery."},{"key":"233_CR62","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.ejcb.2006.01.015","volume":"85","author":"S Arnhold","year":"2006","unstructured":"Arnhold S, Klein H, Klinz FJ, Absenger Y, Schmidt A, Schink\u00f6the T, et al. Human bone marrow stroma cells display certain neural characteristics and integrate in the subventricular compartment after injection into the liquor system. Eur J Cell Biol. 2006;85:551\u201365.","journal-title":"Eur J Cell Biol"},{"key":"233_CR63","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/glia.20731","volume":"57","author":"YJ Kim","year":"2009","unstructured":"Kim YJ, Park HJ, Lee G, Bang OY, Ahn YH, Joe E, et al. Neuroprotective effects of human mesenchymal stem cells on dopaminergic neurons through anti-inflammatory action. Glia. 2009;57:13\u201323.","journal-title":"Glia."},{"key":"233_CR64","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1038\/70978","volume":"5","author":"GT Liberatore","year":"1999","unstructured":"Liberatore GT, Jackson-Lewis V, Vukosavic S, Mandir AS, Vila M, McAuliffe WG, et al. Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease. Nat Med. 1999;5:1403\u20139.","journal-title":"Nat Med"},{"key":"233_CR65","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1046\/j.1460-9568.2002.01938.x","volume":"15","author":"F Cicchetti","year":"2002","unstructured":"Cicchetti F, Brownell AL, Williams K, Chen YI, Livni E, Isacson O. Neuroinflammation of the nigrostriatal pathway during progressive 6-OHDA dopamine degeneration in rats monitored by immunohistochemistry and PET imaging. Eur J Neurosci. 2002;15:991\u20138.","journal-title":"Eur J Neurosci"},{"key":"233_CR66","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1002\/glia.20841","volume":"57","author":"L Bai","year":"2009","unstructured":"Bai L, Lennon DP, Eaton V, Maier K, Caplan AI, Miller SD, et al. Human bone marrow-derived mesenchymal stem cells induce Th2-polarized immune response and promote endogenous repair in animal models of multiple sclerosis. Glia. 2009;57:1192\u2013203.","journal-title":"Glia"},{"key":"233_CR67","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.coi.2010.10.012","volume":"22","author":"A Uccelli","year":"2010","unstructured":"Uccelli A, Prockop DJ. Why should mesenchymal stem cells (MSCs) cure autoimmune diseases? Curr Opin Immunol. 2010;22:768\u201374.","journal-title":"Curr Opin Immunol"},{"key":"233_CR68","first-page":"106","volume":"10","author":"R Zhang","year":"2013","unstructured":"Zhang R, Liu Y, Yan K, Chen L, Chen XR, Li P, et al. Anti-inflammatory and immunomodulatory mechanisms of mesenchymal stem cell transplantation in experimental traumatic brain injury. J Neuroinflammation. 2013;10:106.","journal-title":"J Neuroinflammation"},{"key":"233_CR69","doi-asserted-by":"crossref","first-page":"3982","DOI":"10.1002\/jcp.26192","volume":"233","author":"D Lo Furno","year":"2018","unstructured":"Lo Furno D, Mannino G, Giuffrida R. Functional role of mesenchymal stem cells in the treatment of chronic neurodegenerative diseases. J Cell Physiol. 2018;233:3982\u201399.","journal-title":"J Cell Physiol"},{"key":"233_CR70","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jneuroim.2009.09.003","volume":"216","author":"YX Chao","year":"2009","unstructured":"Chao YX, He BP, Tay SS. Mesenchymal stem cell transplantation attenuates blood brain barrier damage and neuroinflammation and protects dopaminergic neurons against MPTP toxicity in the substantia nigra in a model of Parkinson\u2019s disease. J Neuroimmunol. 2009;216:39\u201350.","journal-title":"J Neuroimmunol"},{"key":"233_CR71","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s13273-015-0038-y","volume":"11","author":"JS Lee","year":"2015","unstructured":"Lee JS, Song DY, Cho WG, Lee JY, Park YS, Yang YC, et al. Transplantation of human mesenchymal stem cells into the cisterna magna and its neuroprotective effects in a parkinsonian animal model. Mol Cell Toxicol. 2015;11:373\u201385.","journal-title":"Mol Cell Toxicol"},{"key":"233_CR72","doi-asserted-by":"crossref","first-page":"431","DOI":"10.2217\/rme.15.17","volume":"10","author":"A Schwerk","year":"2015","unstructured":"Schwerk A, Altsch\u00fcler J, Roch M, Gossen M, Winter C, Berg J, et al. Adipose-derived human mesenchymal stem cells induce long-term neurogenic and anti-inflammatory effects and improve cognitive but not motor performance in a rat model of Parkinson\u2019s disease. Regen Med. 2015;10:431\u201346.","journal-title":"Regen Med"},{"key":"233_CR73","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.retram.2016.10.007","volume":"65","author":"A Gugliandolo","year":"2017","unstructured":"Gugliandolo A, Bramanti P, Mazzon E. Mesenchymal stem cell therapy in Parkinson\u2019s disease animal models. Curr Res Transl Med. 2017;65:51\u201360.","journal-title":"Curr Res Transl Med"},{"key":"233_CR74","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s13770-017-0026-5","volume":"14","author":"M Khalilpourfarshbafi","year":"2017","unstructured":"Khalilpourfarshbafi M, Hajiaghaalipour F, Selvarajan KK, Adam A. Mesenchymal stem cell-based therapies against podocyte damage in diabetic nephropathy. Tissue Eng Regen Med. 2017;14:201\u201310.","journal-title":"Tissue Eng Regen Med."},{"key":"233_CR75","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s13770-017-0093-7","volume":"14","author":"D Kim","year":"2017","unstructured":"Kim D, Cho GS, Han C, Park DH, Park HK, Woo DH, et al. Current understanding of stem cell and secretome therapies in liver diseases. Tissue Eng Regen Med. 2017;14:653\u201365.","journal-title":"Tissue Eng Regen Med"},{"key":"233_CR76","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0006-8993(02)03582-5","volume":"957","author":"K Okada","year":"2002","unstructured":"Okada K, Matsunaga K, Yuhi T, Kuroda E, Yamashita U, Tsuji S. The long-term high-frequency repetitive transcranial magnetic stimulation does not induce mRNA expression of inflammatory mediators in the rat central nervous system. Brain Res. 2002;957:37\u201341.","journal-title":"Brain Res"},{"key":"233_CR77","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/WNR.0b013e328335b411","volume":"21","author":"X Yang","year":"2010","unstructured":"Yang X, Song L, Liu Z. The effect of repetitive transcranial magnetic stimulation on a model rat of Parkinson\u2019s disease. Neuroreport. 2010;21:268\u201372.","journal-title":"Neuroreport"},{"key":"233_CR78","first-page":"564095","volume":"2015","author":"Q Dong","year":"2015","unstructured":"Dong Q, Wang Y, Gu P, Shao R, Zhao L, Liu X, et al. The neuroprotective mechanism of low-frequency rTMS on nigral dopaminergic neurons of Parkinson\u2019s disease model mice. Parkinsons Dis. 2015;2015:564095.","journal-title":"Parkinsons Dis"},{"key":"233_CR79","doi-asserted-by":"crossref","first-page":"50921","DOI":"10.18632\/oncotarget.17285","volume":"8","author":"M Ba","year":"2017","unstructured":"Ba M, Ma G, Ren C, Sun X, Kong M. Repetitive transcranial magnetic stimulation for treatment of lactacystin-induced Parkinsonian rat model. Oncotarget. 2017;8:50921\u20139.","journal-title":"Oncotarget"},{"key":"233_CR80","doi-asserted-by":"publisher","DOI":"10.1080\/00207454.2018.1495632","author":"HJ Wang","year":"2018","unstructured":"Wang HJ, Tan G, Zhu LN, Chen D, Xu D, Chu SS, et al. The efficacy of repetitive transcranial magnetic stimulation for Parkinson disease patients with depression. Int J Neurosci. https:\/\/doi.org\/10.1080\/00207454.2018.1495632.","journal-title":"Int J Neurosci"},{"key":"233_CR81","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s10517-018-4128-4","volume":"165","author":"LI Aftanas","year":"2018","unstructured":"Aftanas LI, Gevorgyan MM, Zhanaeva SY, Dzemidovich SS, Kulikova KI, Al\u2019perina EL, et al. Therapeutic Effects of repetitive transcranial magnetic stimulation (rTMS) on neuroinflammation and neuroplasticity in patients with Parkinson\u2019s disease: a placebo-controlled study. Bull Exp Biol Med. 2018;165:195\u20139.","journal-title":"Bull Exp Biol Med"}],"container-title":["Tissue Engineering and Regenerative Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13770-019-00233-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13770-019-00233-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13770-019-00233-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T00:42:37Z","timestamp":1611189757000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13770-019-00233-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,22]]},"references-count":81,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["233"],"URL":"https:\/\/doi.org\/10.1007\/s13770-019-00233-8","relation":{},"ISSN":["1738-2696","2212-5469"],"issn-type":[{"value":"1738-2696","type":"print"},{"value":"2212-5469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,22]]},"assertion":[{"value":"15 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All experimental procedures performed in this work involving animals were approved by the institutional Animal Care and Use Committee at Yonsei University Wonju College of Medicine (Identification code: YWC-090828-1) and procedures were performed in accordance with the guidelines of the National Institutes of Health\u2019s Guide for the Care and Use of Laboratory Animals.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}}]}}